LivingGLP1
Study S002499

Clinical and Genetic Variations Study of Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients

ClinicalTrials.gov record

Registration

Registration
NCT02026024
Acronym
IBCT2
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
10
Start
2013-10
Primary completion
2015-12
Lead sponsor
Chang Gung Memorial Hospital
Conditions
Type 2 Diabetes Mellitus
Results posted
FALSE

Registered primary outcomes

  • mean amplitude of glycaemic excursions (MAGE) [3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.